Cargando…
YAP1 regulates prostate cancer stem cell-like characteristics to promote castration resistant growth
Castration resistant prostate cancer (CRPC) is a stage of relapse that arises after various forms of androgen ablation therapy (ADT) and causes significant morbidity and mortality. However, the mechanism underlying progression to CRPC remains poorly understood. Here, we report that YAP1, which is ne...
Autores principales: | Jiang, Ning, Ke, Binghu, Hjort-Jensen, Kim, Iglesias-Gato, Diego, Wang, Zhun, Chang, Pengcheng, Zhao, Yang, Niu, Xiaodan, Wu, Tao, Peng, Bo, Jiang, Mingdong, Li, Xiaoshi, Shang, Zhiqun, Wang, Qiang, Chang, Chawnshang, Flores-Morales, Amilcar, Niu, Yuanjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777753/ https://www.ncbi.nlm.nih.gov/pubmed/29383141 http://dx.doi.org/10.18632/oncotarget.23014 |
Ejemplares similares
-
LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex
por: Shang, Zhiqun, et al.
Publicado: (2019) -
AB007. Neurotensin derived from cancer stroma contributes to castration resistance via promoting neuroendocrine transdifferentiation
por: Zhu, Shimiao, et al.
Publicado: (2016) -
Neutrophil–lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysis
por: Wang, Zhun, et al.
Publicado: (2018) -
Correction: Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer
por: Zhu, Shimiao, et al.
Publicado: (2019) -
Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer
por: Zhu, Shimiao, et al.
Publicado: (2019)